Facebook Twitter YouTube RSS
  • Search this Website
Sama - Resource Group for Women and Health
 
Skip to content
  • About Us
    • Our Vision & Mission
    • Intervention Strategies
    • Member – Government Committees
    • Annual Reports
    • Our Trustees
    • Donors
    • FCRA Information
  • Our Work
    • Pandemics & Covid-19
      • Helplines
      • Statements
      • High Court Order
      • Articles
      • Community Voices
      • Relief & Other Support for Covid-19
      • Intersectional Feminist Framework
      • Consultations on Gender, Equity & Covid-19 Vaccines
      • Webinar Series Pandemics & Public Health
      • Webinar Series on Vaccine Research & Access
      • Webinars on Covid-19
      • Videos and Podcasts
    • Public Health & Right to Health
    • Surrogacy & ARTs
      • Conference Participation & Seminars
      • Workshops & Discussions
      • Reports & Studies
      • Consultations
      • Film / Media
      • Policy Level Advocacy
      • Publications
      • Media Resources
    • Gender Based Violence
    • Reproductive and Disability Justice & Sickle Cell Disease
    • Sexual and Reproductive Health
    • Ethics in Clinical Trials, Access to Medicines
    • Young Women and Mental Health
    • Bioethics
    • Early Marriage and Health
    • Population Policies & Two Child Norm
  • Publications
    • Research Reports
    • Consultation Reports
    • Policy Briefs
    • Capacity Building Tools
    • Fact Finding Reports
    • Articles and Edited Volumes
    • Blogposts
    • Posters
    • Films & Videos
  • Archives
    • Clinical Trials
      • General
      • Affordability
      • Availability & Accessability
      • Compensation
      • Informed Consent
      • Recuritment
      • Bioethics
      • Guidelines & Legislations
  • Photo Gallery
  • Contact
  • Support Us

Category: Clinical Trials

Guidelines for bioavailability and bioequivalence studies

  By admin Archives, Clinical Trials, Guidelines & Legislations

Central Drugs Standard Control Organization, Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, New Delhi | March 2005 Read full article   Continue reading

Drugs and Cosmetics (2nd Amendment) Rules

  By admin Archives, Clinical Trials, Guidelines & Legislations

Ministry of Health and Family Welfare (Department of Health), New Delhi | 20 January 2005 Read full article   Continue reading

Apex committee on clinical trials gives approval to 33 proposals of clinical trials

  By admin Archives, Clinical Trials, Guidelines & Legislations

Ramesh Shankar | PharmaBiz.com | Mumbai | 12 November 2014 The Apex Committee on clinical trials, constituted by the Union health ministry on the directive of the Supreme Court to monitor the clinical trial sector in the country, has cleared a total… Continue reading

Interventions to improve research participant’s understanding in informed consent for research: A systematic review

  By admin Clinical Trials, Informed Consent

Flory, J., & Emanuel, E. | JAMA | 6 October 2004 | Vol. 292, No. 13 | Aim of article: To review research on interventions to improve research participants understanding of information disclosed in the informed consent process Read original… Continue reading

Clinical trials in India: Pangs of globalization

  By admin Archives, Clinical Trials, General

A. Bhatt | Indian Journal of Pharmacology | Vol 36, Issue 4 | July-August 2004 Clinical trials in developing countries are exploding. It is estimated that 20-30% of global clinical trial activities are being conducted in developing countries.[1] The 2002… Continue reading

Seeking informed consent to cancer clinical trials: describing current practice

  By admin Archives, Clinical Trials, Informed Consent

Brown R. F., Butow P. N., Ellis P., Boyle F., Tattersall M. H. | Social Science and Medicine | June 2004 | NCBI-PubMed Abstract Clinical trials have come to be regarded as the gold standard for treatment evaluation. However, many… Continue reading

«‹1718192021›»
  • What’s New

    • Health without violence: Comprehensive response to GBV
    • Multiple Patriarchies, Collective Struggles: Gender Justice, Laws and Perspectives
    • Multiple Patriarchies, Collectivised Struggles: An online session
    • Shifting Perspectives: Recognising GBV as a Public Health Issue
    • Short course on GBV in Bhopal
    • We will miss you, Philo …
    • “Can we hear the cuckoo’s voice?”: The unforgettable Vivaldi and the climate crisis
    • Webinar: Racial and Structural Disparities in Health: Rights, Treatment, and Care for People with SCD
    • 16 Days of Activism Against GBV 2024
    • Short Course on Addressing GBV as a Public Health Concern
    • Challenging Control: The Continuing Struggle for Sexual and Reproductive Health Rights
  • Building Capacities and Leadership

    Our training and capacity-building initiatives are designed to strengthen women’s and young people’s (especially young women and girls) leadership in rural and peri-urban … Read more »

  • Research

    Over the last 25 years, Sama – Resource Group for Women and Health has conducted research on wide-ranging issues related to women’s health, public health, mental health, gender-based violence (GBV), and sexual and reproductive … Read more »

  • Advocacy

    With our strong and expanding connections at both the policy and grassroots levels, we are well placed to shape policy initiatives that reflect ground realities. We also create platforms that support community … Read more »

  • Knowledge Creation

    The knowledge resources we create cover a broad range of formats, including research papers, essays, articles, podcasts, training modules, policy briefs, information guides, videos, booklets, and posters … Read more »

  • About Us
  • Our Work
  • Publications
  • Archives
  • Photo Gallery
  • Contact
  • Support Us
© Sama – Resource Group for Women and Health, 2021
Powered by Parabola & WordPress.
Facebook Twitter YouTube RSS